Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Goldman Sachs Reaffirms Their Sell Rating on CME Group (CME)

Tipranks - Tipranks - Tue Mar 17, 7:18AM CDT

In a report released today, from Goldman Sachs maintained a Sell rating on CME Group, with a price target of $275.00.

Claim 70% Off TipRanks Premium

CME Group has an analyst consensus of Hold, with a price target consensus of $297.56.

See the top stocks recommended by analysts >>

Based on CME Group’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.65 billion and a net profit of $1.17 billion. In comparison, last year the company earned a revenue of $1.53 billion and had a net profit of $874.6 million

Based on the recent corporate insider activity of 95 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CME in relation to earlier this year. Earlier this month, Elizabeth Cook, a Director at CME sold 1,000.00 shares for a total of $320,000.00.

Read More on CME:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).